The global Electron Microscope Market size is expected to reach USD 5.7 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 7.4% over the forecast period. Rising investment in research and increasing use of electron microscopes in industries such as semiconductors, life sciences, and materials research Industries is anticipated to boost the market growth. Developing countries offer new investment avenues to the global market giants. The developing infrastructure and increasing research investments are driving the demand for advanced medical devices in these countries. Microscopes are used extensively in the field of semiconductors. In the field of life sciences, they can be used in clinical trials, toxicology, pathology, diagnosis of diseases, and various other sub disciplines. Microscopy can also be used for characterization of materials, to study their internal structures, and various other applications. They are used in forensics, food industry, healthcare, and chemical among other industries. Few of the key players in the electron microscopes market are Nikon Metrology Inc.; Thermo Fisher Scientific.; ZEISS, International; JEOL Ltd.; Angstrom Advanced Inc.; Hirox Europe Ltd.; and Hitachi High-Technologies Europe GmbH. Regional and service portfolio expansions and mergers and acquisitions are the key strategic undertakings adopted by these players. For instance, in June 2018, Thermo Fischer Scientific acquired electron microscope software console from Roper technologies. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/electron-microscopes-market Further key findings from the study suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/
0 Comments
The global Mouth Ulcers Treatment Market size is projected to reach USD 1.32 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 3.8% during the forecast period. Increasing geriatric population and rising awareness towards oral hygiene are among the key trends stimulating market growth. Growing global geriatric population is poised to trigger the number of cases of mouth ulcers. As per the findings of the United Nations Organization (UNO), population base of age 60 years or older across the globe was 962.0 million in 2017, which was more than twice as large as in 1980, when the population was 382.0 million. With upswing in the demand for denture fittings in this population, rise in the incidences of improper fittings and deficiency of vitamin B & folic acid is anticipated. Such incidents can lead to mouth ulcers. Newly fitted dentures takes some time to adjust. During the procedure, inner area of the mouth remains moist for a certain period. Such conditions favor fungal infection leading to ulcer. Older population often suffer from such conditions, due to which they are prone to oral problems. In addition, deficiency of vitamins is a common phenomenon observed among geriatric population, which also increases the probability of suffering from mouth ulcer. Rising awareness regarding oral hygiene in developing countries is also estimated to drive the market over the forecast period. Campaigns on oral hygiene in rural areas of developing countries are working in favor of the market. For instance, every year, Colgate-Palmolive Company conducts an oral health month in rural areas of India in order to impart awareness regarding oral hygiene. Such initiatives are expected to encourage people to take up necessary treatments. Furthermore, rise in tobacco usage in countries such as U.K. and Mexico is projected to boost the rate of mouth ulcers, thereby benefitting the growth of the market. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/mouth-ulcers-treatment-market Further key findings from the report suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ Global Bench-Top Dental Autoclaves Market is expected to reach USD 64.35 million by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of dental disorder and rising patient awareness levels pertaining to sterilization are some major growth impacting drivers of this market. With remote and mobile healthcare access becoming the need of the hour, bench-top dental autoclaves are expected to witness a surge in demand over the next six years. In addition, growing number of initiatives aimed at curbing hospital acquired healthcare infections related expenditure via sterilization is expected to enhance market demand during the forecast period. Automatic bench-top autoclaves are the most lucrative segment of this market and are expected to grow at a CAGR of over 6.5% during the forecast period. Growing demand for automatic bench-top dental autoclaves, on account of its ability to render error free and faster results is one of the major factors accounting for the segment’s rapid growth. Additionally, North American and European countries pursuing device automation, is expected to positively impact market growth over the next six years. Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/bench-top-dental-autoclave-market Further key findings from the study suggest:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Healthcare IT Market is anticipated to reach USD 104.5 billion by 2020, according to a new report by Grand View Research, Inc. Increasing demand for enhanced healthcare facilities and introduction of technologically advanced systems are expected to boost industry growth. Increasing geriatric population prone to chronic diseases resulting into high patient base is triggering the demand for sophisticated healthcare facilities. Furthermore, increasing number of patients requiring home healthcare acts as an effective growth driver for this market. According to a report published by the U.S. Centers for Disease Control and Prevention (CDC) in 2011, the number of patients needing home healthcare was nearly 4.7 million in the U.S. and is on a constant rise, which is further expected to fuel the healthcare IT market demand. Advent of technologically advanced software, such as interoperable system and cloud computing, is expected to attract more investors focus on developing integrated healthcare system to curb problems associated with conventional procedures of record keeping. For example, the uses of e-healthcare record system to maintain patient database help to provide instant information about patients’ health in case of emergency. Telecommunication and telehealth accounted for over 40.0% of the market share owing to the high usage rates in 2013. Introduction of technological advancements such as Teleimmersive Environment for Everybody (TEEVE) and Session Initiation Protocol (SIP) are the factors promoting this segment’s growth. Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/healthcare-it-market Electronic Health Records (EHR) is expected to register an upward shift to reach up to USD 26.72 billion in 2020. Growth is primarily driven by the rising demand for integrated information system in the field of healthcare IT. Faster accessibility and low maintenance cost are the two most significant factors contributing towards the rising demand of these EHR systems. In 2013, North America market was valued at around USD 20.0 billion owing to the factors such as favorable government initiatives pertaining to the introduction of technologically advanced healthcare IT facilities, sophisticated healthcare infrastructure, and increasing patient awareness levels coupled with relatively higher healthcare expenditures in the region. On the other hand, Asia Pacific healthcare IT market is expected to reach at over USD 19.6 billion by registering lucrative growth rate in 2020. Growth is attributed to the rising healthcare expenditure, larger untapped opportunities, and growing disposable income level. Prominent players operating in this industry include Athenahealth Inc., GE Healthcare, Agfa Healthcare, Philips Healthcare, E-MDS Inc., Carestream Health McKesson Corporation, Carestream Health eClinicalworks, and Hewlett-Packard. About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Precision Medicine (Diagnostics/Therapeutics) Market size is expected to reach USD 85.5 billion by 2025 at a 9.9% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth. The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe. Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas. Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before. Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies. At present, more than 40% of the medications in biotech and pharmaceutical companies’ improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/precision-medicine-diagnostics-therapeutics-market Further key findings from the report suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Minimally Invasive Surgical Instruments Market size is expected to reach USD 38.3 billion by 2025 according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 9.7% over the forecast period. The preference for Minimally Invasive Surgical (MIS) procedures is rising as they are less traumatic and they facilitate faster recover process than traditional open surgeries. Minimal invasive technologies are designed to reduce trauma, blood loss, scarring, and chances of infection than traditional open surgeries. Patients can resume their daily activities in shorter time after these surgical procedures. In addition, the costs involved in minimally invasive surgeries are significantly less than in-patient and conventional open surgeries. Therefore, MIS procedures prove to be beneficial for patients as well as payers. The benefits of MIS in various areas of orthopedics have contributed to the growing demand for less traumatic alternatives with minimum tissue disruption of bones. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/minimally-invasive-surgical-instruments-market Further key findings from the study suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Single-Use Bioprocessing Market size is expected to reach USD 26.89 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 13.6% during the forecast period. Low cost associated with operations and construction is recognized as the key factor stimulating the sales of and demand for disposable products. Single-use solutions have made significant inroads at various biomanufacturing stages as a reliable and cost-effective alternative. In addition, integration of single-use technology (SUTs) in continuous bioprocess engineering is anticipated to fuel the usage of disposables. Rising pressure to meet the growing demand for biopharmaceuticals is expected to significantly impact the adoption of SUTs within the bioprocessing industry. Hence, this space is also expected to be benefitted by the rapid growth of biologics. Moreover, SUT helps in enhancing operational capacity, which in turn, prompts biopharmaceutical companies to adopt disposable equipment. Growing popularity of contract services for bioproduction has played a major role in reshaping the SUT’s landscape. Furthermore, understanding the advantages of disposable biomanufacturing equipment, firms have been investing in breakthrough innovations and incremental changes to augment the scope of disposables. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/single-use-bioprocessing-market Further key findings from the report suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Healthcare Contract Research Organization (CRO) Market size is expected to reach USD 54.7 billion by 2025, according to a new study by Grand View Research Inc. It is anticipated to expand at a CAGR of 6.6% during the forecast period. Increasing cost of drug development is expected to drive the growth. Drug maker and sponsor companies are under pressure to replace the revenue loss caused by generics, increasing patent expirations, number of partnerships to identify biologics, and growing R&D costs, which has made drug development more expensive and complex.
Regulatory framework for drug discovery and drug development is complex in various countries. Thus, an increasing need for expertise in different areas of drug development is driving the demand for outsourcing services. Drug companies are not only outsourcing production of medicines, but also clinical trials. With increasing privatization of clinical trials, there has been an increase in outsourcing of manufacturing processes to developing regions such as India, China, and Latin American countries. China and India are projected to witness tremendous growth in near future, owing to their treatment naïve patient pool coupled with high disease prevalence. Furthermore, genetically diverse population, highly qualified investigators, and well-equipped hospitals are other factors creating growth opportunities in India for global clinical trials market. In addition, growing pressure on market players to follow stringent timelines has increased the demand for outsourcing of research activities. Even government organizations are outsourcing their clinical trial activities to CROs so that they can carry out the clinical trials with the required infrastructure, expertise, and minimize cost and timelines. In 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI). In January 2016, Charles River Laboratories International, Inc. entered into a definitive agreement to acquire WIL Research for approximately USD 585 million. The acquisition is expected to strengthen Charles’ ability to partner with global clients. The high R&D spending in oncology has also fueled the need for healthcare contract research outsourcing. Realizing this demand, France-based laboratory, XenTech increased its capacity of its animal care to 50% along with increasing collaborative research projects. CROs are in a process of continuously improving their portfolio by integrating services with technology. This enables them to save more on time and deliver efficient and desired results to the clients. In June 2016, LSK Global Pharma Services Co., Ltd. expanded the use of Medidata Clinical Cloud by Medidata Clinical Solutions, Inc. Established in the year 2000, the company conducts clinical trials at both local and global scale. It utilizes Medidata’s electronic data capture, unified randomization, medical coding solution, and trial management supply solution. In addition to offering improved services, CROs are in the process of collaborating to promote their services at a global level. For instance, In June 2017, PAREXEL entered into a merger agreement with West Street Merger Sub, Inc., a wholly-owned subsidiary of West Street Parent, LLC. According to the merger agreement, PARAXEL will survive as a subsidiary of West Street Parent, LLC, in a transaction valued at approximately USD 5.5 billion. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/healthcare-contract-research-outsourcing-market Further key findings from the study suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Acne Drugs Market size is expected to reach USD 5.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a 4.2% CAGR during the forecast period. Several factors such as emergence of biologics, unhealthy lifestyle, and rising disease incidence are anticipated to drive the market. Acne vulgaris is one of the most common dermatological disorders, affecting 9.4% people worldwide. Although the condition can affect people of all ages, it is most prevalent among teenagers. It has been found that the condition is prevalent in more than 85.0% people between the ages of 12 and 25. Acne can appear in forms ranging from comedones to cystic lesions, depending on its severity. Retinoids and antibiotics remain the mainstays of acne treatment. Retinoids led the therapeutic classes in 2017, and it is expected to continue this trend through 2025. The therapeutic landscape is witnessing a shift toward combination treatment due to higher efficacy, convenient dosing, and fewer adverse effects. By mode of administration, topical drugs currently dominate the market. Severe cases see the use of systemic medications such as oral antibiotics, hormonal agents, or other drugs. However, emergence of biologics (Gevokizumab and RA-18C3) will fuel the injectable route of administration. Biologics offer improved clinical advantage over conventional topical treatments since they target inflammatory mechanisms with disease modifying ability. Discontinuation or termination of key pipeline candidates on account of unsuccessful clinical trials is a major restraint this market faces. Upon launch, Olumacostat glasaretil (Dermira; topical lipid synthesis inhibitor) was expected to be the first topical anti-acne drug with isotretinoin-like results without significant side effects. However, the drug failed to meet clinical endpoints, leading to discontinuation in March 2018. Similarly, SNA-001 (Sienna; silver nanoparticles solution) was deemed unsuccessful in two key trials wherein it was tested in conjunction with 810nm and 1064nm lasers in July 2018. Thesan withdrew TSN2898 from Phase II trials due to drug unavailability. Xenon discontinued development of XEN801 after the drug failed Phase II clinical trials. Despite being one of the most common dermatological diseases in the world, innovation in acne treatment has been rather limited over the past decade. Drug companies are currently exploring novel treatment approaches including stearoyl CoA desaturase inhibition, melanocortin receptor antagonism, and anti-IL-1 monoclonal antibodies. Impending launch of late-stage pipeline products indicate a promising future for the global acne drugs market. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/acne-drugs-market Further key findings from the report suggest:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ The global Antibiotics Market size is expected to reach USD 62.06 billion by 2026 expanding at a CAGR of 4.0%, according to a new report by Grand View Research, Inc. Rising prevalence of infectious diseases, especially in developing regions like Asia Pacific and Middle East, is anticipated to contribute to the market growth. More than 15.0% of the deaths in children below the age of five years, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the disease is highly prevalent in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one-third of the infected population, thereby increasing the disease burden. Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the forecast period. This is further expected to facilitate development of advanced drugs. According to an article published by the Pew Charitable Trusts, nearly 30% of the outpatient oral antibiotics prescriptions are unnecessary and majority of these are prescribed for disease conditions, such as non-bacterial infections and acute respiratory conditions, against which antibiotics are not significantly effective. Such indiscriminate use of antibiotics is anticipated to increase the risk of difficult-to-treat antibiotic-resistant infections, thereby increasing the economic burden. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/antibiotic-market Further key findings from the study suggest:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ |
Archives
October 2023
|